ArticleSAGE open medicine2025
Pharmacist knowledge, attitude, and practice regarding nicotine replacement therapy usage in Iraq.
Article in SAGE open medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The tobacco epidemic represents one of the most significant public health challenges faced globally. Nicotine replacement therapy was developed to substitute for the nicotine contained in tobacco products temporarily. The objective of this study was to investigate pharmacists' knowledge, attitudes, and practices regarding the utilization of nicotine replacement therapy in Iraq. Methods: This cross-sectional study involved 300 pharmacists across five provinces from October 1, 2023 to December 31, 2023. Results: Indicate that 300 pharmacists participated in the analysis, with approximately two-thirds identifying as male. About two-thirds of the participants (95% confidence interval: 65.3%) expressed that they knew how to use nicotine replacement therapy. Furthermore, about half of them (95% confidence interval: 50.3%) reported their awareness of how to make dose titration, with a majority agreeing that the assessment of nicotine dependence influences the selection of nicotine replacement therapy products. Fair knowledge was associated with each degree of education, not attending training programs, and the availability of nicotine replacement therapy in their pharmacies (0.01, 0.002, 0.003, respectively). Conclusions: There exists a critical necessity for pharmacists to augment their comprehension of the medications utilized in smoking cessation. Such enhancement is essential to improve their practices and, consequently, to attain superior outcomes in supporting individuals in their efforts to quit smoking.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.